| Clinical data | |
|---|---|
| Other names | Endiemal, metharbitone, methobarbitone[1] |
| Routes of administration | By mouth (tablets) |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.011 |
| Chemical and physical data | |
| Formula | C9H14N2O3 |
| Molar mass | 198.222 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Metharbital was patented in 1905 byEmil Fischer working forMerck.[2] It was marketed asGemonil byAbbott Laboratories. It is abarbiturateanticonvulsant, used in the treatment ofepilepsy.[3][4] It has similar properties tophenobarbital.
Metharbital can be synthesized from 2,2-diethylmalonic acid andO-methylisourea.[5][6][2]
Thisanticonvulsant-related article is astub. You can help Wikipedia byexpanding it. |